Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
HITS logo — AI Drug Discovery & Development

HITS

AI Drug Discovery & Development

Founded 2020 Korea South Korea South 63 employees

General Information

Company Name HITS
Founded Year 2020
Location Korea South Korea South +1
Employees 63
Social

Get notified when HITS moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About HITS

HITS is a groundbreaking startup in the field of AI Drug Discovery & Development, founded in 2020. The company aims to revolutionize the inefficiencies in the drug development process, providing faster therapeutic opportunities for patients with unmet medical needs. Through the introduction of Lab Automation, HITS transforms the paradigm of bio R&D from simple predictive tools to comprehensive research planning and execution.

Utilizing its proprietary AI Orchestration technology, HITS integrates and analyzes complex biological data effectively, leading the industry's technical transformation. The company leverages its HyperLab, powered by the nationally acclaimed AI model K-Fold, to enhance the precision and speed of drug development to world-class standards.

HITS has met stringent criteria for the newly established "AI 기술특례상장," preparing strategically for a successful IPO. As a key player in the 'AI 특화 파운데이션 모델 개발' project led by the Ministry of Science and ICT, the company is creating a next-gen model set to elevate South Korea's global standing in bio AI technology.

Taxonomy: AI Drug Discovery, Lab Automation, AI Orchestration, Compound Screening, Bioinformatics, AI Models, K-Fold Model, Co-Scientist AI, Biotech Innovation, Biopharmaceuticals, Global Commercialization, AI-driven Research, Life Sciences, Advanced Analytics, Virtual Screening

Services & Products

AI Drug Design
Virtual Screening Solutions
ADME/T Prediction Models
Hyper Lab Technologies Development

Target Customers

Pharmaceutical Companies Biotechnology Research Institutions Medicinal Chemists and Drug Designers Contract Research Organizations (CROs)

No funding data available for HITS yet.

Get notified when HITS raises funding

HITS Alternatives & Competitors

HITS vs
BELIFT LAB
BELIFT LAB

Lift to be moved

25 employees
Education, Entertainment
HITS vs
상화(Sangwha)
상화(Sangwha) Korea South

BE BOLD BY TECHNOLOGY

Series Unknown
9 employees
Content Creators, Digital Media

FAQ About HITS

AI Drug Discovery & Development
HITS was founded in 2020.
HITS is headquartered in Korea South.
HITS has approximately 63 employees.
HITS offers: AI Drug Design, Virtual Screening Solutions, ADME/T Prediction Models, Hyper Lab Technologies Development.
Top alternatives and competitors to HITS include BELIFT LAB, 상화(Sangwha). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
HITS and BELIFT LAB are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors HITS and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy